Zealand Pharma A/S (CPH:ZEAL)
Denmark · Delayed Price · Currency is DKK 466.40
-17.30 (-3.58%)
At close: Dec 30, 2025
Zealand Pharma Market Cap
Zealand Pharma has a market cap or net worth of 32.85 billion as of December 31, 2025. Its market cap has decreased by -39.61% in one year.
Market Cap
32.85B
Enterprise Value
17.09B
Revenue
9.16B
Ranking
n/a
PE Ratio
5.09
Stock Price
466.40
Market Cap Chart
Since November 24, 2010, Zealand Pharma's market cap has increased from 1.41B to 32.85B, an increase of 2,237.02%. That is a compound annual growth rate of 23.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 32.85B | -35.01% |
| Dec 30, 2024 | 50.55B | 132.03% |
| Dec 29, 2023 | 21.79B | 110.16% |
| Dec 30, 2022 | 10.37B | 65.31% |
| Dec 30, 2021 | 6.27B | -28.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.45T |
| Genmab | 124.86B |
| Coloplast | 123.14B |
| ALK-Abelló | 50.56B |
| Demant | 45.84B |
| H. Lundbeck | 41.40B |
| Ambu A/S | 23.42B |
| GN Store Nord | 15.54B |